Latest filing published 04 Mar 2026 for METLIFE INC, €257k.
Marlene Debel appears in 48 filings: 42 at Metlife Inc, under the title EVP & Chief Risk Officer, and 6 at Raymond James Financial Inc, as a Director. Trades run from February 25, 2020 to March 2, 2026.
No purchase. The 4 sales total EUR 3,202,398, with a median of EUR 562,729, and all are at Metlife Inc. The largest, EUR 1,804,929, is dated December 13, 2024; the next two, EUR 584,977 and EUR 540,482, May 11, 2021 and August 9, 2023. Grants make up most of the record with 31 filings, ahead of 13 option exercises.
The yearly pace is stable from one year to the next: 8 filings in 2020, 2023 and 2024, 7 in 2021 and 2022, 5 in 2025 and 2026. Five filings fall in the last twelve months, with neither a purchase nor a sale.
Filings are published a median of 2 days after the trade.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 48 declarations